Dachille Douglas A. 4
4 · BridgeBio Pharma, Inc. · Filed Aug 26, 2021
Insider Transaction Report
Form 4
Dachille Douglas A.
Director
Transactions
- Award
Stock Option (right to buy)
2021-08-17+49,869→ 49,869 totalExercise: $49.54Exp: 2031-08-16→ Common Stock (49,869 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in three annual installments after August 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.